RPAY vs TECH · rev $313.0M vs P/E 65, rev $1.22B
Repay Holdings Corp (RPAY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Repay Holdings Corp (RPAY) is a software - infrastructure company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RPAY revenue for 2024-12-31 was $313.0M. Net income was -$10.3M. Revenue was up 5.5% from 2023-12-31 to 2024-12-31. RPAY currently screens at market cap $292.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RPAY currently screens at market cap $292.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RPAY and TECH stock pages for the full models.
Not investment advice.